As of 12:38:27 PM EST. Market Open. EMERYVILLE, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of its ...

XOMA (NASDAQ:XOMA – Get Free Report) was upgraded by investment analysts at StockNews.com from a “sell” rating to a “hold” rating in a note issued to investors on Tuesday. Separately, HC Wainwright ...

EMERYVILLE, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of its Executive Team will participate at the ...

These figures are adjusted for non-recurring items. XOMA acquires Kinnate Biopharma for $2.3352 per share, with potential additional cash. The acquisition is expected to close in April 2024.

$XOMA insiders have traded $XOMA stock on the open market 10 times in the past 6 months. Of those trades, 4 have been purchases and 6 have been sales. Here’s a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...